单细胞分析揭示了神经保护性基因素脱乙酶抑制剂途径
Madeline Peyton1,2,3, Nur Jury-Garfe4,5, Jiahui Liu1
1Department of Biostatistics and Health Data Science, Indiana University Indianapolis, Indianapolis, Indiana, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|February 3, 2026
概括
这项研究确定了Trichostatin-A (TSA) 作为潜在的阿尔茨海默病 (AD) 治疗方法,表明它可以保护神经元和保护突触. 蛋白质DISC1 (精神分裂症中断1) 是调解这些神经保护作用的关键标.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 的特点是β-粉样蛋白 (Aβ) 斑块,陶,和神经炎症,导致认知能力下降.
- 目前对阿尔茨海默病的疾病修饰疗法有限,需要新的治疗策略.
- 这项研究整合了先进的奥米克技术,以发现AD的新药候选者.
研究的目的:
- 通过计算药物重定向来识别用于阿尔茨海默病 (AD) 的可重定向药物.
- 在临床前模型中研究已识别的候选药物的治疗潜力.
- 阐明候选药物的神经保护作用背后的分子机制.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 和空间转录组学用于AD皮层组织的细胞类型特定分析.
- 计算药物重定位确定了Trichostatin-A (TSA) 作为一个顶级候选者.
- 在实验室验证中,使用暴露于Aβ寡合体的人类诱导多能干细胞 (iPSC) 衍生神经元证实了TSA的有效性.
主要成果:
- 在神经元模型中,trichostatin-A (TSA) 证明了对Aβ毒性的显著神经保护,并保持了突触完整性.
- 干扰性精神分裂症1 (DISC1) 在TSA治疗的神经元和特定AD相关细胞群中被发现是上调的.
- DISC1表达与保护性微质亚型相关,这表明它在AD病变发生和对治疗的反应中的作用.
结论:
- DISC1成为阿尔茨海默病 (AD) 的一个融合治疗点.
- 通过涉及GSK3β,线粒体运输和突触可塑性的途径,DISC1调解了TSA的神经保护作用.
- 这项研究为开发针对DISC1通路的新型AD疗法提供了机制基础.
关键词:
AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD ADD was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was阿尔茨海默氏症的疾病是阿尔茨海默氏症.在 DISC1 中.在HDAC的基础上,HDAC是运输安全局 (TSA) 的情况.粉样蛋白-β-β 的存在.药物重用是为了改变药物的用途.基因素脱乙酶抑制剂 基因素脱乙酶抑制剂微质细胞中的微质细胞神经炎症是一种神经炎症.神经保护神经保护在 scRNA-seqq 中.一个单细胞RNA测序.三素-A-A 的使用情况.相关概念视频
Histone Modification
16.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.1K
Histone Modification
4.5K
4.5K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Histone Variants at the Centromere
5.1K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
C4 Pathway and CAM
49.2K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
C4 Pathway
The C4 pathway is used by plants such as...
49.2K
Other Glycolytic Pathways
909
The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
909


